High DND1 Level Indicates a Poor Prognostic Factor in Prostate Cancer

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static-preview.hindawi.com/articles/dm/volume-2021/9948241/figures/9948241.fig.002a.svgz" name="9948241.fig.002a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>Cancer</td></tr><tr class="fig-image" id="b"><td><object data="https://static-preview.hindawi.com/articles/dm/volume-2021/9948241/figures/9948241.fig.002b.svgz" name="9948241.fig.002b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>Cancer</td></tr><tr class="fig-image" id="c"><td><object data="https://static-preview.hindawi.com/articles/dm/volume-2021/9948241/figures/9948241.fig.002c.svgz" name="9948241.fig.002c" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(c) </b>Normal prostate tissue</td></tr></table>

<div>Immunostaining of DND1 in prostate cancer and adjacent normal prostate tissues. (a) Immunostaining showed strong positive DND1 in the cytoplasm of prostate cancer cells. (b) Immunostaining showed moderate positive DND1 in the cytoplasm of prostate cancer cells. (c) DND1 was negatively expressed in adjacent normal prostate tissues.</div>

Disease Markers

fig2

Figure 2

Figure 2: High DND1 Level Indicates a Poor Prognostic Factor in Prostate Cancer 